Search Results - "Lebedev, Timofey D."

Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.

Authors: Vagapova, Elmira R. Lebedev, Timofey D. Prassolov, Vladimir S.

Source: Scientific Reports. 5/27/2021, Vol. 11 Issue 1, p1-14. 14p.

Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors.

Authors: Lebedev, Timofey D. Khabusheva, Elmira R. Mareeva, Sofia R. et al.

Source: Journal of Biological Chemistry. Aug2022, Vol. 298 Issue 8, p1-16. 16p.

Subjects: Protein-tyrosine kinase inhibitors, Cell lines, Colon cancer

Transmission of Non-Constitutive Proteasomes Between Cells via Extracellular Vesicles.

Authors: Grigorieva, Ekaterina V. Burov, Alexander V. Starodubova, Elizaveta S. et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p466. 19p.

Piperazine-Substituted Pyranopyridines Exhibit Antiproliferative Activity and Act as Inhibitors of HBV Virion Production.

Authors: Buloyan, Sona Harutyunyan, Arpine Gasparyan, Hrachik et al.

Source: International Journal of Molecular Sciences. May2025, Vol. 26 Issue 9, p3991. 23p.

Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis.

Authors: Nikitenko, Natalia A. Speiseder, Thomas Groitl, Peter et al.

Source: Biochimie. Jun2015, Vol. 113, p10-16. 7p.

Corrigendum to “Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis” [Biochimie 113C (2015) 10–16].

Authors: Nikitenko, Natalia A. Speiseder, Thomas Groitl, Peter et al.

Source: Biochimie. Sep2015, Vol. 116, p166-166. 1p.

Improving the power of drug toxicity measurements by quantitative nuclei imaging.

Authors: Mikheeva AM Bogomolov MA Gasca VA et al.

Source: Cell death discovery [Cell Death Discov] 2024 Apr 18; Vol. 10 (1), pp. 181. Date of Electronic Publication: 2024 Apr 18.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

Authors: Lebedev TD Vagapova ER Popenko VI et al.

Source: Frontiers in oncology [Front Oncol] 2019 Oct 18; Vol. 9, pp. 1046. Date of Electronic Publication: 2019 Oct 18 (Print Publication: 2019).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.

Authors: Vagapova ER Lebedev TD Prassolov VS

Source: Scientific reports [Sci Rep] 2021 Aug 30; Vol. 11 (1), pp. 17658. Date of Electronic Publication: 2021 Aug 30.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE